HOUSE_OVERSIGHT_028422.jpg
Extracted Text (OCR)
drugs.html?partner=applenewsé&ad
keywords=APPLEMOBILE®ion=written throughé&asset_id=100000006090758", "range": {"length"
766, "start":0},"type":"link"}],"identifier":" anf-body-2", "layout": "related-
Link", "role":"body", "text™:"Celgene to Pay $280 Million to Settle Fraud Suit Over
Cancer Drugs July 25, 2017","textStyle":"related-
link", "type™:"text"}, {"identifier":" anf-divider-3", "layout": "ComponentLayout-—
10", "role":"divider", "stroke": {"color":"#e2e2e2"}, "type"™:"line"™}, {"additions"™: [{"URL™:"
https://www.nytimes.com/2018/08/05/nyregion/senator-menendez-election
nj-.html?partner=applenewséad
keywords=APPLEMOBILE®ion=written throughé&asset_id=100000006090758", "range": {"length"
798, "start":0},"type":"link"}],"identifier":" anf-body-3", "layout": "related-
link", "role":"body","text":"In Deeply Blue New Jersey, an Unexpected Battle for Senate
Aug. 5, 2018","textStyle":"related-link", "type": "text"}, {"identifier":" anf-divider-
4", "layout": "ComponentLayout-—
10", "role":"divider", "stroke": {"color":"#e2e2e2"},"type"™:"line"™}, {"additions"™: [{"URL™:"
https://www.nytimes.com/2018/02/13/nyregion/bob-hugin-robert-menendez-senate-new
jerey.html?partner=applenewséad
keywords=APPLEMOBILE®ion=written throughé&asset_id=100000006090758", "range": {"length"
274,"start":0},"type":"link"}],"identifier":" anf-body-4","layout"™:"related-
link", "role":"body", "text":"A Former Pharmaceutical Executive Is Running for U.S.
Senate in New Jersey Feb. 13, 2018", "textStyle":"related-
link", "type":"text"}],"identifier":" anf-section-
3","layout":" defaultComponentLayout", "role":"section", "type":"section"}, {"components":
[{"identifier":" anf-heading4—-5", "layout": "bottom-banner-
head", "role": "heading4","text":"Get the full New York Times
xperience", "textstyle": "bottom-banner-
head", "type": "text"}, {("additions": [{"URL":"https://rvw-
s.tink.io/serve?action=click&publisher id=229811l&site id=50290&my campaign=AppleNews iO
SFusion Footer", "range": {"length":61,"start":0},"type":"link"}],"identifier":" anf-
1 vF
body-5", "layout": "bottom-banner-body", "role": "body", "style":"_anf-cs-3","text":"
-", "textstyle":"bottom-banner-body", "type": "text"}],"identifier":" anf-container-
4","layout":"ComponentLayout-12","role":"container","style":" anf-cs-
1", "type™:"container"}],"documentStyle"™: {"backgroundColor"™: "#FFFFFF"},"identifier":"100
000006090758", "language": "en", "layout": {"columns":8, "gutter":20,"margin":84, "width":102
4}, "metadata": {"campaignData":{"keywords": ["Drugs (Pharmaceuticals)", "Thalidomide
(Drug)","Prices (Fares, Fees and Rates)","Midterm Elections (2018)","Elections,
Senate", "Cancer", "Celgene Corporation","Food and Drug Administration", "Senate", "Hugin,
Robert J","New Jersey", "Menendez,
Robert", "Thalomid", "Revlimid"], "section": ["nyregion"]},"canonicalURL":"https://www.nyti
mes.com/2018/09/24/nyregion/bob-hugin-celgene-robert-menendez
senate. html", "dateModified":"2018-09-24T10:09:00.0002", "datePublished":"2018-09-
24T09:00:01.00024", "generatorName": "papi", "generatorVersion":"v1", "thumbnailiImagelIdentif
ter":"el26e7bde26613f50f2609cb8776d827", "transparentToolbar":false},"resources":{"OVale
24c-£75c-42c9-8bfb-3f5falc7idd2":{"URL":"asset://07ale24c-f£75c-42c9-8bfb
3f5falc/7fdd2","classification": "font", "fileSize":0,"fontAttributes": {"familyName":"NYTC
heltenhamSH
Regular", "style": "normal", "weight":400, "width": "normal"},"fontName": "NYTCheltenhamsSH-
Regular", "identifier":"07ale24c-f75c-42c9-8bfb-3f5falc7idd2", "type": "font"}, "Qad0935b-
£58e-48a5-97dd-658a5f3b6d57":{"URL": "asset: //0ad0935b-£58e-48a5-97dd
658a5f3b6d57","classification":"image", "dimensions": {"height":200, "width":300},"fileSiz
e":0,"identifier":"0ad0935b-f£58e-48a5-97dd
658a5f3b6d57", "imageIdentifier":"S5e552¢aaedbdJaf8c8bade0a70blldad", "type": "image"},"0c2
33c47-aab6b-4b66-aea0-1986dcb4b9c2":{"URL": "asset: //0c233c47-aabb-4b66-aead
1986dcb4b9c2","classification": "font", "fileSize":0,"fontAttributes": {"familyName": "NYTF
ranklin
Medium", "style": "normal", "weight":700,"width":"normal"},"fontName": "NYTFranklin-
Bold", "identifier": "0c233c47-aatb-4b66-aea0-1L986dcb4b9c2", "type": "font"}, "Oe3e5286-
5659-48 6a-9302-397ba82e69870": {"URL": "asset: //0e3e65286-5659-486a-9302
397ba82e9870","classification": "image", "dimensions": {"height":1365, "width":2048},"files
ize":0,"identifier":"0e3e5286-5659-486a—-9302
397ba82e9870","imageldentifier": "5e5526aaedbd7af8c8bade0a70blida0", "type"™:"image"},"179
8lfab-7743-4c53-a295-elc452ledlia":{"URL":"asset://17981fab-7743-4c53-a295
elc4521ledila", "classification": "font","fileSize":0,"fontAttributes": {"familyName":"NYTF
ranklin
Medium", "style": "normal", "weight":500, "width": "normal"},"fontName":"NYTFranklin-
Medium", "identifier":"17981fab-7743-4c53-a295-elc4521ledila", "type": "font"}, "1d413a81-
3170-4a92-9bf9-cd09ec717b7c": {"URL": "asset: //1d413a81-3170-4a92-9bf9
HOUSE_OVERSIGHT_028422
Extracted Information
Dates
Document Details
| Filename | HOUSE_OVERSIGHT_028422.jpg |
| File Size | 0.0 KB |
| OCR Confidence | 85.0% |
| Has Readable Text | Yes |
| Text Length | 5,000 characters |
| Indexed | 2026-02-04T17:03:47.519625 |